PRIMECAP MANAGEMENT CO/CA/ - MEREO BIOPHARMA GROUP PLC ownership

MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 59 filers reported holding MEREO BIOPHARMA GROUP PLC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PRIMECAP MANAGEMENT CO/CA/ ownership history of MEREO BIOPHARMA GROUP PLC
ValueSharesWeighting
Q3 2023$101,910
-51.0%
79,000
-49.9%
0.00%
Q2 2023$208,164
-0.7%
157,700
-46.8%
0.00%
Q1 2023$209,617
-6.0%
296,530
-0.2%
0.00%
Q4 2022$222,922
-17.7%
297,230
-5.6%
0.00%
Q3 2022$271,000
-24.7%
314,760
-2.1%
0.00%
Q2 2022$360,000
-3.0%
321,660
-2.8%
0.00%
Q1 2022$371,000
-30.3%
330,900
-0.4%
0.00%
Q4 2021$532,000
-35.3%
332,200
-2.2%
0.00%
-100.0%
Q3 2021$822,000
-47.0%
339,600
-30.5%
0.00%0.0%
Q2 2021$1,550,000
-5.9%
488,938
-0.0%
0.00%0.0%
Q1 2021$1,648,000
-5.9%
489,1000.0%0.00%0.0%
Q4 2020$1,751,000
+36.7%
489,1000.0%0.00%0.0%
Q3 2020$1,281,000
-14.4%
489,1000.0%0.00%0.0%
Q2 2020$1,497,000
+167.3%
489,100
-10.0%
0.00%0.0%
Q1 2020$560,000
-71.6%
543,375
-9.7%
0.00%0.0%
Q4 2019$1,974,000
-0.4%
601,762
-11.9%
0.00%
-50.0%
Q3 2019$1,982,000
+18.6%
683,356
-1.8%
0.00%
+100.0%
Q2 2019$1,671,000696,1100.00%
Other shareholders
MEREO BIOPHARMA GROUP PLC shareholders Q1 2023
NameSharesValueWeighting ↓
Rubric Capital Management LP 16,756,120$18,767,0000.99%
Clearline Capital LP 3,058,596$3,426,0000.44%
SUVRETTA CAPITAL MANAGEMENT, LLC 9,142,067$10,239,0000.39%
DAFNA Capital Management LLC 1,096,513$1,228,0000.34%
Octagon Capital Advisors LP 1,000,000$1,120,0000.30%
Rock Springs Capital Management LP 6,230,275$6,978,0000.20%
Boxer Capital, LLC 2,250,000$2,520,0000.16%
Orbimed Advisors 7,109,954$7,963,0000.14%
Artal Group S.A. 1,500,000$1,680,0000.09%
SECTORAL ASSET MANAGEMENT INC 385,000$431,0000.09%
View complete list of MEREO BIOPHARMA GROUP PLC shareholders